The most widely used diagnostic tests for syphilis can’t differentiate between an active infection and a past one. They’re not good at identifying early and late disease and can’t diagnose congenital syphilis. UVic’s Caroline Cameron and research partners in the US and Spain are working to change that.
International researchers led by University of Victoria microbiologist Caroline Cameron are developing a vaccine for syphilis, an ancient disease that is, once again, increasingly prevalent. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in the US is supporting the project with US$7.8 million over five years to engineer a hybrid protein with a goal of preventing infectious and congenital syphilis.
Four decades after the start of a pandemic that has claimed 40 million lives, University of Victoria researchers are putting the stories of British Columbians who lived through the early days of the HIV/AIDS epidemic in the spotlight. HIV In My Day, a community-based oral history project led by School of Public Health and Social Policy Associate Professor Nathan Lachowsky, captures the stories of 120 long-term HIV survivors and caregivers.
HIV In My Day, a community-based oral history project that gathered the stories of HIV survivors and caregivers during the early years of BC’s HIV/AIDS epidemic, has been adapted into a play. In My Day will premiere in Vancouver at The Cultch theatre, the day after World AIDS Day. The play takes its script from almost 120 oral history interviews collected from 2017 to 2020 as part of a University of Victoria-led research project.
UVic microbiologist Caroline Cameron receives $2M grant from Open Philanthropy to develop a direct diagnostic test and vaccine for syphilis, one of the world’s first global diseases.
UVic researcher tests potential application of nanoparticles in cancer treatment.
Showcasing people and projects at UVic--experts can talk to media about the many initiatives to create gender inclusivity in STEM to celebrate February 11.
UVic’s new campus-wide Communicable Disease (CD) Plan is now available, following the recent release of the provincial Post-Secondary Return-to-Campus Guidelines.
How tiny gold particles injected into tumours could improve radia
The COVID-19 crisis has shown that pandemics belong as much to the present as the past. From Ebola to HIV/AIDs to Zika, University of Victoria historian Mitchell Hammond says disease has played an increasingly significant role in global affairs in recent decades. Hammond shares what we can learn from the pandemics of the past.
Diabetes is a disease often associated with obesity but a new study led by sociologist Karen Kobayashi indicates that Japanese Americans who are not overweight are at a much higher risk of developing the disease. The new research points to the vital need for health screening in this population.
University of Victoria microbiologist Caroline Cameron will co-chair the world’s largest international conference on sexually transmitted infections (STIs), including HIV, in Vancouver from July 14 to 17. In an expert Q&A, she discusses some of the global challenges.
Lower-energy radiation could increase access to common cancer treatment
University of Victoria microbiologist Caroline Cameron and colleagues have received a patent for a potential vaccine candidate against syphilis.
UVic microbiologist Caroline Cameron has been awarded a patent for a potential vaccine candidate against syphilis. While the bacterial disease dates back to at least 1495 and is treatable with antibiotics, its highly infectious nature makes it an enduring health issue.
A UVic researcher studying the epidemic of HIV and sexually transmitted infection in B.C. among men who have sex with men is one of 20 health researchers in the province selected by the Michael Smith Foundation for Health Research for a 2017 Scholar Award.
